Abstract
Serum IGFBP3 levels were tested in 7 GHD children before the rGH therapy, at the end of the same therapy and 1, 2, 4, and 8 weeks later. The IGFBP3 concentration returned to the pre-therapy levels only 6 weeks after the end of the therapy.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Carrier Proteins / blood*
-
Child
-
Child, Preschool
-
Female
-
Follow-Up Studies
-
Growth Disorders / drug therapy*
-
Growth Hormone / administration & dosage*
-
Growth Hormone / deficiency
-
Growth Inhibitors / blood*
-
Humans
-
Insulin-Like Growth Factor Binding Proteins
-
Male
-
Radioimmunoassay
-
Recombinant Proteins / administration & dosage
-
Somatomedins / analysis*
-
Time Factors
Substances
-
Carrier Proteins
-
Growth Inhibitors
-
Insulin-Like Growth Factor Binding Proteins
-
Recombinant Proteins
-
Somatomedins
-
Growth Hormone